|
|
|
瑞銀(盧森堡)生化股票基金
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
780.46 |
-8.32 |
-1.05% |
2020/07/10 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 14.32% |
1.85% |
32.71% |
54.62% |
41.28% |
1.57% |
-17.08% |
25.45% |
-13.98% |
29.08% |
| 瑞銀(盧森堡)生化股票基金(美元)
| |
本基金主要投資於全球生化科技產業中從事研究、產品開發、產品製造及配銷的公司股票;選股著重於個別公司之市場地位及該公司之管理與獲利能力，以獲得來自該產業的利益。本基金的投資目標在於透過積極的基金管理方式，達到最佳之投資績效，同時將投資風險降至最低。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/07/10 |
780.46 |
-1.05% |
2020/06/25 |
776.20 |
-0.22% |
| 2020/07/09 |
788.78 |
-0.34% |
2020/06/22 |
777.89 |
0.77% |
| 2020/07/08 |
791.47 |
0.44% |
2020/06/19 |
771.92 |
3.61% |
| 2020/07/07 |
788.02 |
1.36% |
2020/06/18 |
745.04 |
0.55% |
| 2020/07/06 |
777.41 |
0.47% |
2020/06/17 |
741.00 |
1.23% |
| 2020/07/02 |
773.81 |
0.77% |
2020/06/16 |
731.98 |
1.74% |
| 2020/07/01 |
767.88 |
0.59% |
2020/06/15 |
719.48 |
1.52% |
| 2020/06/30 |
763.34 |
1.38% |
2020/06/12 |
708.70 |
0.78% |
| 2020/06/29 |
752.94 |
-0.80% |
2020/06/11 |
703.24 |
-3.88% |
| 2020/06/26 |
759.05 |
-2.21% |
2020/06/10 |
731.63 |
0.62% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-1.05% |
0.86% |
6.67% |
27.08% |
18.37% |
33.52% |
19.03% |
| NBI生技指數 |
-1.45% |
-1.55% |
7.18% |
19.83% |
15.21% |
30.07% |
13.84% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-2.54% |
-1.81% |
5.74% |
21.35% |
12.97% |
24.23% |
13.58% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-1.51% |
3.74% |
10.39% |
1.58% |
14.80% |
2.18% |
| MSCI 製藥指數 (price) |
0.00% |
-1.78% |
2.00% |
6.27% |
-2.35% |
11.48% |
-1.74% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.57% |
7.56% |
14.42% |
15.31% |
38.61% |
15.61% |
|
0.35% |
-0.96% |
4.29% |
12.41% |
5.34% |
16.76% |
5.95% |
|
0.35% |
-0.98% |
4.26% |
12.13% |
4.82% |
15.60% |
5.39% |
|
-1.27% |
0.52% |
8.81% |
17.55% |
14.14% |
31.46% |
14.41% |
|
-0.73% |
0.53% |
2.56% |
16.30% |
7.77% |
13.86% |
8.03% |
|
0.68% |
-0.58% |
3.95% |
7.57% |
1.67% |
16.33% |
3.46% |
|
1.10% |
-0.35% |
4.45% |
11.75% |
3.78% |
17.45% |
4.71% |
|
-0.35% |
-1.71% |
5.50% |
13.28% |
6.98% |
19.87% |
7.46% |
|
-0.62% |
0.28% |
2.36% |
13.86% |
7.64% |
10.18% |
8.17% |
|
-0.74% |
0.23% |
2.75% |
15.95% |
9.13% |
15.96% |
9.99% |
|
1.82% |
3.32% |
18.20% |
37.56% |
13.52% |
45.14% |
12.56% |
|
0.91% |
-1.21% |
3.02% |
6.29% |
-2.83% |
10.05% |
-1.14% |
|
-1.21% |
-0.79% |
7.81% |
22.68% |
13.59% |
26.88% |
13.21% |
|
-1.22% |
-0.80% |
7.71% |
22.30% |
12.87% |
25.22% |
12.41% |
|
-0.28% |
-1.35% |
2.57% |
10.78% |
-3.35% |
10.07% |
-2.61% |
|
-0.83% |
-1.97% |
5.95% |
15.33% |
4.58% |
15.79% |
4.18% |
|
-0.85% |
-2.00% |
5.87% |
15.03% |
4.06% |
14.63% |
3.60% |
|
-0.82% |
-1.98% |
5.85% |
14.99% |
3.40% |
12.77% |
2.90% |
|
-0.81% |
-1.96% |
5.91% |
15.20% |
3.80% |
13.65% |
3.32% |
|
-0.85% |
-1.96% |
6.02% |
15.55% |
4.99% |
16.67% |
4.58% |
|
-0.83% |
0.35% |
2.48% |
13.30% |
11.01% |
18.96% |
11.99% |
|
0.15% |
0.53% |
8.49% |
22.24% |
17.19% |
27.07% |
15.88% |
|
-0.27% |
0.32% |
8.10% |
18.10% |
16.03% |
29.04% |
15.80% |
|
0.16% |
0.55% |
8.60% |
22.70% |
18.45% |
30.27% |
17.20% |
|
1.08% |
0.19% |
4.30% |
14.96% |
-0.02% |
6.88% |
0.14% |
|
0.65% |
-0.01% |
3.92% |
11.05% |
-0.99% |
8.58% |
0.10% |
|
1.09% |
0.21% |
4.40% |
15.38% |
1.08% |
9.63% |
1.32% |
|
-0.47% |
-0.58% |
0.43% |
11.76% |
0.28% |
12.62% |
1.25% |
|
-0.49% |
0.50% |
2.36% |
12.83% |
8.98% |
24.13% |
10.16% |
|
-0.46% |
0.69% |
2.11% |
15.04% |
5.83% |
21.45% |
6.34% |
| 基金平均績效 |
-0.19% |
-0.34% |
5.32% |
16.03% |
7.07% |
19.02% |
7.33% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
